Restricting Symptoms Before and After Admission to Hospice

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

Pierre Charbel Atallah, MD, Pierre Atallah, MD, Vikram Kashyap, MD

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Bleeding Toes in Diabetic Neuropathy

Carlos J. Rodriguez, MD, MPH, Martha L

Sexuality The American Journal of Medicine

What Started This? Debilitating Longitudinally-extensive Myelitis

An Unusual Cause of Leg Ulcerations

Comparative Effectiveness Research and Medical Informatics

Bleeding Toes in Diabetic Neuropathy

Emilee R. Wilhelm-Leen, BA, Yoshio N. Hall, MD, Manjula K

Maureen M. Okam, MD, MPH, Todd A. Koch, Minh-Ha Tran, DO

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Dietary Fiber Intake and Cardiometabolic Risks among US Adults, NHANES

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

One Appendix, Two Different Pains

Leslie R. Harrold, MD, MPH, Daniel Peterson, MS, Ashley J

Methemoglobinemia: A Diagnosis Not to Be Missed

Overview of Current Learning Theories for Medical Educators

Nisha I. Parikh, MD, MPH, Michael J. Pencina, PhD, Thomas J

Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population Mark Viron, MD, Travis Baggett, MD, MPH, Michele.

Urinary Ascites and Renal Failure from Unrecognized Bladder Rupture

Paul D. Stein, MD, Afzal Beemath, MD, Frederick A

Epidemiology of Myelodysplastic Syndromes

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Incident Gout in Women and Association with Obesity in the Atherosclerosis Risk in Communities (ARIC) Study Janet W. Maynard, MD, MHS, Mara A. McAdams.

Risk Factors for Work Disability in Severe Adult Asthma

Osteoporotic Fractures and Heart Failure in the Community

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Tick Tock The American Journal of Medicine

Challenges in the Clinical Management of Blood-Culture Negative Endocarditis: Case of Bartonella henselae Infection Divya Gupta, MD, Jacqueline Green,

The Reply The American Journal of Medicine

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Gun Ownership and Firearm-related Deaths

Loop Diuretics for Heart Failure-associated Hyponatremia

Gout in African Americans

Are We Missing Diagnosis of Large Vessel Vasculitis

Carlos Aguilar, MD, Valentin del Villar, MD

Bromide Toxicity from Consumption of Dead Sea Salt

Catherine Buettner, MD, MPH, Matthew J. Rippberger, MA, Julie K

The Malnourished Heart: An Unusual Case of Heart Failure

Insulin Order Sets Improve Glycemic Control and Processes of Care

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Thomas M. Gill, MD, Evelyne A. Gahbauer, MD, MPH, Peter H

Prevalence and Risk Factors for Erectile Dysfunction in the US

Insomnia in the Elderly: Cause, Approach, and Treatment

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Cluster Syncope The American Journal of Medicine

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Evaluation of Severe Infection and Survival After Splenectomy

Shikhar Agarwal, MD, MPH The American Journal of Medicine

Purple Urinary Bag Syndrome

A Post-cure Complication

Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes John A. Dodson, MD, Tuyet-Trinh N. Truong,

Sister Mary Joseph's Node

Plasma Lactescence in Acute Pancreatitis

Barriers to Adult Immunization

Primary Care Management of Skin Abscesses Guided by Ultrasound

Screening and Treatment of Vitamin D Deficiency on Hospital Admission: Is There a Benefit for Medical Inpatients? Lena Grädel, MD, Meret Merker, BMSc,

Trends in Prolonged Hospitalizations in the United States from 2001 to 2012: A Longitudinal Cohort Study Lauren Doctoroff, MD, Douglas J. Hsu, MD, Kenneth.

Diagnosing Bilateral Tarsal Tunnel Syndrome

Falls in Older Adults: Risk Assessment, Management and Prevention

Has mortality from acute renal failure decreased

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Jay S. Kaufman, PhD, Sam Harper, PhD The American Journal of Medicine

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

Restricting Symptoms Before and After Admission to Hospice Shayan Cheraghlou, BA, Evelyne A. Gahbauer, MD, MPH, Linda Leo-Summers, MPH, Hans F. Stabenau, PhD, Sarwat I. Chaudhry, MD, Thomas M. Gill, MD The American Journal of Medicine Volume 129, Issue 7, Pages 754.e7-754.e15 (July 2016) DOI: 10.1016/j.amjmed.2016.02.017 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Occurrence of any restricting symptoms (A) and mean number of restricting symptoms (B) in the 12 months before and 3 months after hospice admission. Values for the prevalence of symptoms were calculated by dividing the number of participants who reported any restricting symptoms that month by the total number of participants who completed interviews in the month. Error bars in (A) represent the asymptotic standard error. Errors in (B) represent the standard error. Dashed vertical line denotes the time of hospice admission. Months before hospice admission are denoted by negative values, whereas those afterwards are denoted by positive values. The number of participants varies before hospice admission because of missing values and decreases after hospice admission because of deaths. The American Journal of Medicine 2016 129, 754.e7-754.e15DOI: (10.1016/j.amjmed.2016.02.017) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Occurrence of specific restricting symptoms in the 12 months before and 3 months after hospice admission. Symptoms were categorized a priori according to how amenable they might be to hospice treatment: (A) most; (B) intermediate; (C) least. Values for the prevalence of symptoms were calculated by dividing the number of participants that reported the particular restricting symptom that month by the total number of participants who completed interviews in the month. Dashed vertical lines denote the time of hospice admission. Months before hospice admission are denoted by negative values, whereas those afterwards are denoted by positive values. The number of participants varies before hospice admission because of missing values and decreases after hospice admission because of deaths. The American Journal of Medicine 2016 129, 754.e7-754.e15DOI: (10.1016/j.amjmed.2016.02.017) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Occurrence of any restricting symptoms (A, B) and mean number of restricting symptoms (C, D) in the 12 months before and 3 months after hospice admission by hospice admission diagnosis and sex. Values for the prevalence of symptoms were calculated by dividing the number of participants that reported the particular restricting symptom that month by the total number of participants who completed interviews in the month. Dashed vertical line denote the time of hospice admission. Months before hospice admission are denoted by negative values, whereas those afterwards are denoted by positive values. The number of participants varies before hospice admission because of missing values and decreases after hospice admission because of deaths. At 3 months, none of the 5 survivors with organ failure had any restricting symptoms. The American Journal of Medicine 2016 129, 754.e7-754.e15DOI: (10.1016/j.amjmed.2016.02.017) Copyright © 2016 Elsevier Inc. Terms and Conditions

Supplemental Figure Occurrence of specific restricting symptoms in the 12 months before and 3 months after hospice admission among participants with at least one post-hospice interview. Symptoms were categorized a priori according to how amenable they might be to hospice treatment: (A) most; (B) intermediate; (C) least. Values for the prevalence of symptoms were calculated by dividing the number of participants that reported the particular restricting symptom that month according to the total number of participants who provided interviews in the month. Dashed vertical lines denote the time of hospice admission. Months before hospice admission are denoted by negative values, whereas those afterwards are denoted by positive values. The number of participants varies before hospice admission because of missing values and decreases after hospice admission because of deaths. The American Journal of Medicine 2016 129, 754.e7-754.e15DOI: (10.1016/j.amjmed.2016.02.017) Copyright © 2016 Elsevier Inc. Terms and Conditions